Author

M. Tachibana

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Biochemistry· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 2 Organism:mouse· 2 Assay:ATAC-seq· 1 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Organism:non-human primate· 1 Assay:proteomics· 1

Frequent Co-Authors

N. Okada· 2 shared Z. Xie· 2 shared D. Hamanaka· 1 shared D. Okuzaki· 1 shared H. H. Ibrahim· 1 shared H. Zhou· 1 shared J. M. Lee· 1 shared K. Kurihara· 1 shared

Activity by Year

2022-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

N. Okada

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Myeloid-derived suppressor cells exacerbate poly(I:C)-induced lung inflammation in mice with renal injury and older mice

Z. Xie, H. Zhou, M. Obana, Y. Fujio, N. Okada, M. Tachibana

This study shows that increased myeloid-derived suppressor cells (MDSCs) in mice with renal injury or aging worsen lung inflammation caused by viral pneumonia.

bioRxiv · Jun 7, 2023 · PreprintImmunology

HDAC1-3 inhibition reduces CCR2 expression and immunosuppressive function of myeloid-derived suppressor cells

Z. Xie, Y. Okada, D. Okuzaki, N. Okada, M. Tachibana

This study shows HDAC1-3 inhibitors reduce CCR2 expression and immunosuppressive function of MDSCs, enhancing antitumor effects in HCC.

bioRxiv · Jun 1, 2023 · PreprintImmunology

Highly efficient protein expression of Plasmodium vivax surface antigen, Pvs25 by silkworm, Bombyx mori, and its biochemical analysis.

T. Miyata, K. Minamihata, K. Kurihara, Y. Kamizuru, M. Gotanda, M. Obayashi, T. Kitagawa, K. Sato, M. Kimura, K. Oyama, Y. Ikeda, Y. Tamaki, J. M. Lee, K. Sakao, D. Hamanaka, , H. H. Ibrahim

This study expresses and purifies recombinant Pvs25 from silkworms, demonstrating its potential as a malaria transmission-blocking vaccine candidate with high immunogenicity.

bioRxiv · Mar 3, 2022 · PreprintBiochemistry